A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
Ocellaris Pharma, Inc.
Ocellaris Pharma, Inc.
Young Adult Survivors United
Sanofi
Cancer Trials Ireland
NuCana plc
National Institutes of Health Clinical Center (CC)
Numab Therapeutics AG
NantBioScience, Inc.
Aminex Therapeutics, Inc.
Pfizer
GlaxoSmithKline
Samsung Bioepis Co., Ltd.
CytomX Therapeutics
National Institutes of Health Clinical Center (CC)
NBE-Therapeutics AG
Hoffmann-La Roche
Oncorus, Inc.
West Virginia University
Duke University
Myriad Genetic Laboratories, Inc.
University of Arkansas
Queen's University, Belfast
National Institutes of Health Clinical Center (CC)
AbbVie
National Institutes of Health Clinical Center (CC)
Lumos Pharma
Pfizer
InSightec
Dartmouth-Hitchcock Medical Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Novartis
Pfizer
CureOne
Pfizer
Tampere University Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Pfizer
AbbVie
AbbVie
GlaxoSmithKline
Vanderbilt-Ingram Cancer Center
Celldex Therapeutics
AbbVie
Pfizer
Masonic Cancer Center, University of Minnesota
Institut Curie
Oxford University Hospitals NHS Trust
Baylor Breast Care Center
Centre Francois Baclesse